Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-30T17:04:11.452Z Has data issue: false hasContentIssue false

Vulnerabilidad genética al abuso de drogas

Published online by Cambridge University Press:  12 May 2020

E. Duaux
Affiliation:
Servicio Hospitalario Universitario de Salud Mental y Terapéutica, Hospital de Santa Ana, 75014París, Francia
M.O. Krebs
Affiliation:
Servicio Hospitalario Universitario de Salud Mental y Terapéutica, Hospital de Santa Ana, 75014París, Francia
H. Loo
Affiliation:
Servicio Hospitalario Universitario de Salud Mental y Terapéutica, Hospital de Santa Ana, 75014París, Francia
M.F. Poirier
Affiliation:
Servicio Hospitalario Universitario de Salud Mental y Terapéutica, Hospital de Santa Ana, 75014París, Francia
Get access

Resumen

La adicción a diversas sustancias, incluidas las drogas y el alcohol, se origina probablemente en una combinación de factores ambientales y genéticos. Varios estudios familiares, de adopción y de gemelos apoyan la vulnerabilidad genética a la adicción a las drogas. Sin embargo, como ocurre en otros trastornos mentales, la vulnerabilidad genética a la adicción a las drogas parece compleja: estos trastornos no siguen las reglas de la herencia mendeliana. En su lugar, influyen probablemente en ellos múltiples genes de susceptibilidad, cada uno de los cuales contribuye al trastorno. Cuantos más genes son necesarios para un trastorno, más difÍcil es detectar cualquiera de ellos. El papel de los factores ambientales aumenta esta dificultad. Los estudios de asociación que han utilizado el enfoque del gen candidato pueden identificar genes de susceptibilidad para el abuso de drogas con el apoyo de la hipótesis patofisiológica de la enfermedad. Esta revisión se centrará en los estudios clÍnicos y de genética molecular en el abuso de drogas.

Type
Artículo original
Copyright
Copyright © European Psychiatric Association 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

Benjain, JLi, LPatterson, CGreenberg, BGMurphy, DLHamer, DH.Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nat Gen 1996;12:81–4.CrossRefGoogle Scholar
Berrettini, WHPersico, AM.Dopamine D2 receptor gene polymorphisms and vulnerability to substance abuse in African Americans. Biol Psychiatry 1996;40:144–7.CrossRefGoogle ScholarPubMed
Blum, KSheridan, PWood, RBracermann, EChen, TComings, D.Dopamine D2 receptor ene variants: association and linkage studies in impulsive-addictive-com-pulsive behaviour. Pharmacogenetics 1995;5:121–41.CrossRefGoogle Scholar
Bond, CLaforge, KTian, MMelia, DZhang, SBorg, L, et al.Single-nucleotide polymorphism in the human mu opiod receptor gene alters betaendorphin binding and activity: possible implications for opiate addiction. Proc Nati Acad Sci USA 1998;95:9608–13.CrossRefGoogle Scholar
Cadoret, RJTroughton, EO’Gorman, TWHeywood, E.An adoption study of genetic and environmental factors in drug abuse. Arch Gen Psychiatry 1986;43:1131–6.CrossRefGoogle ScholarPubMed
Cadoret, RJYates, WRTroughton, EWoodworth, GStewart, MA.Adoption studies demonstrating two genetic pathways to drug abuse. Arch Gen Psychiatry 1995;52:4252.CrossRefGoogle ScholarPubMed
Chaudry, HArria, ATarter, RChaudhry, SChaudhry, N.Familial history of opium use and reported problems among opium addicts in Pakistan. Br J Addicts 1991;86:785–8.CrossRefGoogle Scholar
Comings, DEGade, RMuhleman, DChiu, CWu, STo, M, et al.Exon and intron variants in the human tryptophan 2, 3 dioxygenase gene: potential association with Tourette’s syndrome, substance abuse and other disor-ders. Pharmacogenetics 1996;4:307–18.CrossRefGoogle Scholar
Comings, DEGade, RWu, SChiu, CDietz, GMuhleman, D, et al.Studies of the potential role of the dopamine DI receptor gene in addictive behaviors. Mol Psychiatry 1997;2:4456.CrossRefGoogle Scholar
Comings, DEMuhleman, DAhn, CGysin, R Flanagans. The dopamine D2 receptor gene: a genetic risk factor in substance abuse. Drug Alcohol Depend 1994;34:175–80.CrossRefGoogle ScholarPubMed
Comings, DEMuhleman, DGade, RJohnson, PVerde, RSaucier, G, et al.Cannabinoid receptor gene (CNR1): association with IV drug use. Mol Psychiatry 1997;2:161–8.CrossRefGoogle Scholar
Comings, DEMuhleman, DGriffon, NBourdel, MCSautel, FSokoloff, P, et al.Homozygosity at the dopamine D3 receptor gene is associated with opiate depen-dence. Mol Psychiatry 1998;3:333–6.Google Scholar
Duaux, ELaplanche, PGorwood, PBourdel, MCLaunay, JMPoirier, MF.Role of the serotonin transponer promo-ter polymorphism, opiate dependence and suicide attempts. Communication at the IBANGS Meeting, Key Largo, Oct 1999.Google Scholar
Ebstein, RPGritsenko, INemanov, LFrish, AOsher, YBelmaker, RH.No association between the serotonin transponer gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) tem-perament of harm avoidance. Mol Psychiatry 1997;2:224–6.CrossRefGoogle Scholar
Ebstein, RPNovick, OUmansky, RPriel, BOsher, YBlaine, D, et al.Dopamine D4 receptor exon III polymorphism associated with the human personality trait of novelty seeking. Nat Gen 1996;12:7884.CrossRefGoogle ScholarPubMed
Edenberg, HJReynolds, JKoller, DLBegleiter, HBucholz, KKConneally, PM, et al.A family-ased analysis of whe-ther the functional promoter alleles of the serotonin transponer gene 5-HTT affect the risk for alcohol depen-dence. Alcohol Clin Exp Res 1998;22:1080–5.CrossRefGoogle Scholar
Freimer, MKranzler, HSatel, SLacobelle, JSkipsey, KCharney, D, et al.No association between D3 dopamine receptor (DRD3) alleles and cocaine dependence. Addict Biol 1996;1:281–7.CrossRefGoogle ScholarPubMed
Gebhardt, CFüreder, TFruchs, KUrmann, AStompe, TFathi, N, et al.No association of novelty seeking with DRD2 and DRD3 receptor gene polymorphisms [abs-tract]. Am J Med Gen 1998;81:497.Google Scholar
Gelernter, JKranzler, HCubells, J.Genetic of two opiod receptor gene (OPRM1) exon I polymorphisms: popula-tion studies, and allele frequencies in alcohol-and-drug-dependence subjects. Mol Psychiatry 1999;4:476–83.CrossRefGoogle Scholar
Gelernter, JKranzler, HSatel, SL.No association between D2 dopamine receptor (DRD2) alleles or haplotypes and cocaine dependence or severity of coccaine dependence in European-and African-Americans. Biol Psychiatry 1999;45:340–5.CrossRefGoogle ScholarPubMed
Golberg, JLyons, MJEisen, SATrue, WRTsuang, M.Genetic influence on drug use: a preliminary analysis of 2,674 Vietnamera veteran twins [abstract]. Behav Genet 1993;552.Google Scholar
Gorwood, PBatel, P, AdèsJ, Hamon, MBoni, C.Serotonin transponer gene polymorphisms, alcoholism and suicidal behaviour. Biol Psychiatry (in press).Google Scholar
Grave, WMEckert, EDHeston, LBouchard, TJSegal, NLykken, DT.Heritability of substance abuse and antisocial behavior: a study of monozygotic twins reared apart. Biol Psychiatry 1990;27:1293–304.CrossRefGoogle Scholar
Hallikainen, TSaito, TLachman, HMVolavka, JPohjalainen, T, Ryynanen, et al.Association between low activity serotonin transponer promoter genotype and early onset alcoholism with habitual impulsive violent behavior. Mol Psychiatry 1999;4:385–8.CrossRefGoogle Scholar
Helzer, JEBurman, AMcEvoy, LT.Alcohol abuse and dependence. In: Regier, ADRobins, LN, eds. Psychiatric disorders in America. The Epidemiolog Catchment Area Study. Free Press; New York: 1991;81115.Google Scholar
Jorm, AFHenderson, ASJacomb, PAChristensen, HKorten, AERodgers, B, et al.An association study of a functional polymorphism of the serotonin transponer gene with personality and psychiatric symptoms. Mol Psychiatry l998; 3:449–51.CrossRefGoogle Scholar
Kendler, KSKarkowski, LPrescott, CA.Hallucinogen, opiate, sedative and stimulant use and abuse in a popu-lation-based sample of female twins. Acta Psychiatr Scand 1999;5:368–76.Google Scholar
Kessler, RCCrum, RMWarner, LANelson, CBSchulemberg, JAnthony, JC, et al.Lifetine co-occurence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997;54:313–21.CrossRefGoogle Scholar
Kotler, MCohen, HKremer, IMel, HHorowitz, ROhel, N, et al.No association between the serotonin transpor-ter promoter region (5-HTTLPR) and the dopamine D3 receptor (Bal I D3DR) polymorphisms and heroin addic-tion. Mol Psychiatry 1999;4:313–6.CrossRefGoogle Scholar
Kotler, MCohen, HSegrnan, RGritsenko, INemanov, LLere, B, et al.Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Mol Psychiatry 197;2:251–4.CrossRefGoogle Scholar
Kranzler, HGelernter, J, O’Malley, Hernandezavila, CKaufman, D.Association of alcohol or other drug dependence with alleles of the mu opiod receptor gene (OPMR1). Alcohol Clin Exp Res 1998;22:1359–62.Google Scholar
Li, TXu, KDeng, HCai, GLiu, JWang, R, et al.Association analysis of the dopamine D4 gene exon III VNTR and heroin abuse in Chinese subjects. Mol Psychiatry 1997;2:413–6.CrossRefGoogle ScholarPubMed
Luthar, SSAnton, SFMerikangas, KRRounsaville, BJ.Vulnerability to substance abuse and psychopathology among siblings of opioid abusers. J Nerv Ment Dis 1992;180:153–61.CrossRefGoogle ScholarPubMed
Malhotra, AKVirkkunen, M, RooneyW, Eggert, MLinnoila, MGoldman, D.The association between the dopamine D4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty seeking. Mol Psychiatry 1996;1:388–91.Google ScholarPubMed
Mayer, PRochlitz, HRauch, ERommelsacher, HHasse, HESchmidt, SHollt, V.Association between a delta opioid receptor gene polymorphism and heroin dependence in man. Neurorepoit 1997;8:2547–50.CrossRefGoogle ScholarPubMed
Merikangas, KRStolar, MStevens, DEGoulet, JPreisig, MAFenton, B, et al.Familial transmission of substance use disorders. Arch Gen Psychiatry 1998;55:973–9.CrossRefGoogle ScholarPubMed
Miller, NSGold, MSBelkin, BMKlahr, AL.The diagnosis of alcohol and cannabis dependence in cocaine depen-dents and alcohol dependence in their families. Br J Addict 1993;84:1491–8.CrossRefGoogle Scholar
Mirin, SMWeiss, RDGriffin, MLMichael, JL.Psychopathology in drugs abusers and their families. Compr Psychiatry 1991;32:3651.CrossRefGoogle Scholar
Noble, EPBlum, KKhalsa, MERitchie, TMontgomery, AWood, RC, et al.Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend 1993;33:271–85.CrossRefGoogle ScholarPubMed
O’Hara, BFSmith, SSBird, GPersico, AMSuárez, BKCutting, GR, et al.Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in black and Caucasian research volunteers. Hum Hered 1993;43:209–18.Google ScholarPubMed
Ono, YManki, HYoshimura, KMuramatsu, TMizushima, HHiguchi, S, et al.Association between dopamine D4 receptor (DRD4) exon III polymorphism and novelty see-king in Japanese subjects. Am J Med Gen 1997;74:501–3.3.0.CO;2-Q>CrossRefGoogle Scholar
Pickens, RWSuikis, DS.Genetic influences in human substance abuse. Arch Gen Psychiatry 1991;10:202–13.Google ScholarPubMed
Regier, DAFarmer, MERae, DSLocke, BZKeith, SJJudd, LL, et al.Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990;264:2511–8.CrossRefGoogle ScholarPubMed
Rounsaville, BJRosten, TRWeissman, MMPPauls, DAnton, SFMerikangas, K.Psychiatric disorders in the rela-tives of probands with opiate addiction. Arch Gen Psychiatry 1991;488:3342.CrossRefGoogle Scholar
Sander, THarms, HDufeu, PKuhn, SHoehe, MLesh, KP, et al.Serotonin transponer gene variants in alcohol-dependent subjects with dissocial personality disorder. Biol Psychiatry 1998;43:908–12.CrossRefGoogle Scholar
Smith, SSO’Hara, BFPersico, AMGorelick, MANewlin, DBVlahov, D, et al.Genetic vulnerability to drug abuse, the D2 dopamine receptor Taq 1 B1 restriction fragment length polymorphism appears more frequently in poly-substance abusers. Arch Gen Psychiatry 1992;49:723–7.CrossRefGoogle Scholar
Tsuang, MTLyons, MJMeyer, JMDoyle, TEisen, SAGoldberg, J, et al.Co-occurence of abuse of different drugs in men, the role of drug-specific and shared vul-nerabilities. Arch Gen Psychiatry 1998;55:967–72.CrossRefGoogle Scholar
Vandenbergh, DJZonderman, ABWang, JUhl, GRCosta, PT.No association between novelty seeking and dopamine D4 receptor (D4DR) exon III seven repeat alleles in Baltimore Longitudinal Study of Aging participants. Mol Psychiatry 1997;2:417–9.CrossRefGoogle ScholarPubMed
Warner, LAKessler, RCHughes, MAnthony, JCNelson, CB.Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:219–29.CrossRefGoogle ScholarPubMed